EULAT Eradicate… Publications

Publications


Gallstones, Cholecystectomy, and Kidney Cancer: Observational and Mendelian Randomization Results Based on Large Cohorts


Reply - Gastroenterology


Graphical abstract

Gallstones, Body Mass Index, C-Reactive Protein, and Gallbladder Cancer: Mendelian Randomization Analysis of Chilean and European Genotype Data


Graphical abstract

Epigenome-Wide Analysis of Methylation Changes in the Sequence of Gallstone Disease, Dysplasia, and Gallbladder Cancer


Robust Huber-LASSO for improved prediction of protein, metabolite and gene expression levels relying on individual genotype data


Development and internal validation of a multifactorial risk prediction model for gallbladder cancer in a high-incidence country


Gallbladder Cancer Risk and Indigenous South American Mapuche Ancestry: Instrumental Variable Analysis Using Ancestry-Informative Markers


Graphical abstract

Risk of Gynecological Cancers in Cholecystectomized Women: A Large Nationwide Cohort Study


Graphical abstract

Identification of Circulating lncRNAs Associated with Gallbladder Cancer Risk by Tissue-Based Preselection, Cis-eQTL Validation, and Analysis of Association with Genotype-Based Expression


Graphic abstract

RNA Sequencing of Hepatobiliary Cancer Cell Lines: Data and Applications to Mutational and Transcriptomic Profiling


NGS allele counts versus called genotypes for testing genetic association


Graphical abstract

Inbreeding, Native American ancestry and child mortality: linking human selection and paediatric medicine


Graphical abstract

Validation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America


Development of an Application for Electronic Retrieval of Patient and Sample Information in Latin American Regions with a High Incidence of Gallbladder Cancer

Desarrollo de la aplicación EULAT eCollect para el registro electrónico de datos del Consorcio Europeo-Latinoamericano contra el Cáncer de Vesícula Biliar-EULAT Eradicate GBC


EU Flagge
EULAT Eradicate GBC is funded by the European Union’s Horizon 2020 Research and Innovation programme under Grant Agreement Num. 825741